Safety and tolerability of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis: a multicenter, double-blind, placebo controlled randomized clinical trial.
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Rifaximin (Primary) ; Simvastatin (Primary)
- Indications Liver cirrhosis
- Focus Adverse reactions
- Acronyms LIVERHOPE
- 29 Sep 2017 Status changed from not yet recruiting to recruiting.
- 24 Mar 2017 New trial record